# | Drug | Count |
---|---|---|
0 | EVEROLIMUS | 19 |
1 | LAMOTRIGINE | 18 |
2 | OMEPRAZOLE MAGNESIUM | 17 |
3 | OMEPRAZOLE | 16 |
4 | CARBOPLATIN | 15 |
5 | CISPLATIN | 15 |
6 | GEMCITABINE HYDROCHLORIDE | 15 |
7 | NIRAPARIB | 15 |
8 | TRABECTEDIN | 15 |
9 | CLOBAZAM | 14 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | TRABECTEDIN | 15 | 0.0088 |
1 | EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL | 1 | 0.0081 |
2 | POTASSIUM NITRATE AND SODIUM FLUORIDE | 1 | 0.0033 |
3 | CETYLPYRIDINIUM CHLORIDE | 1 | 0.0018 |
4 | PHENOBARBITAL | 12 | 0.0012 |
5 | NIRAPARIB | 15 | 0.0010 |
6 | CLOBAZAM | 14 | 0.0009 |
7 | CLOMIPHENE CITRATE | 1 | 0.0008 |
8 | DESFLURANE | 1 | 0.0007 |
9 | PHENYTOIN | 11 | 0.0006 |
# | Drug class | Count |
---|---|---|
0 | Kinase Inhibitor [EPC] | 22 |
1 | mTOR Inhibitor Immunosuppressant [EPC] | 22 |
2 | Anti-epileptic Agent [EPC] | 20 |
3 | Benzodiazepine [EPC] | 20 |
4 | Mood Stabilizer [EPC] | 19 |
5 | Proton Pump Inhibitor [EPC] | 16 |
6 | Alkylating Drug [EPC] | 15 |
7 | Platinum-based Drug [EPC] | 15 |
8 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 15 |
9 | Nucleoside Metabolic Inhibitor [EPC] | 12 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 15 | 0.0006 |
1 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
2 | Interleukin-2 Receptor Blocking Antibody [EPC] | 1 | 0.0001 |
3 | Mood Stabilizer [EPC] | 19 | 0.0001 |
4 | Alkylating Drug [EPC] | 15 | 0.0001 |
5 | Platinum-based Drug [EPC] | 15 | 0.0001 |
6 | Standardized Chemical Allergen [EPC] | 1 | 0.0001 |
7 | Aromatase Inhibitor [EPC] | 6 | 0.0001 |
8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
9 | Microtubule Inhibitor [EPC] | 7 | 0.0001 |